Home Stock

Stock Research: M1 Kliniken

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

M1 Kliniken

GER:M12 DE000A0STSQ8
81
  • Value
    49
  • Growth
    91
  • Safety
    Safety
    100
  • Combined
    98
  • Sentiment
    10
  • 360° View
    360° View
    81
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

M1 Kliniken AG operates medical centers for aesthetic and plastic treatments, offering services like wrinkle and breast corrections, liposuction, and face lifts. It is primarily in the healthcare and aesthetic medicine industry, with medical centers in Germany (Berlin, Essen, Dusseldorf, Cologne, Munich). In the last fiscal year, the company had a market cap of $331 million, profits of $66 million, revenue of $351 million, and 152 employees.

more

ANALYSIS: With an Obermatt 360° View of 81 (better than 81% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock M1 Kliniken are very positive. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for M1 Kliniken. The consolidated Growth Rank has a good rank of 91, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 91% of competitors in the same industry. In addition, the consolidated Safety Rank has a safer rank of 100 which means that the company has a financing structure that is safer than 100% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the consolidated Value Rank has a less desirable rank of 49 which means that the share price of M1 Kliniken is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is higher than for 51% of alternative stocks in the same industry. The consolidated Sentiment Rank also has a low rank of 10, which means that professional investors are more pessimistic about the stock than for 90% of alternative investment opportunities. ...read more

more
Strongest Rank Pro Holdings
Weakest Rank Safety
Country Germany
Industry Health Care Facilities
Size Small
Website m1-kliniken.de
Index
M1 Kliniken stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 7-Jul-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
49 66 70 77
Growth
91 60 91 61
Safety
Safety
100 100 96 90
Sentiment
10 92 100 87
360° View
360° View
81 100 100 99
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
97 95 97 71
Opinions Change
50 50 89 50
Pro Holdings
n/a 100 78 92
Market Pulse
24 51 55 30
Sentiment
10 92 100 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
49 66 70 77
Growth
91 60 91 61
Safety Safety
100 100 96 90
Combined
98 96 100 96
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
66 69 69 95
Price vs. Earnings (P/E)
85 59 45 88
Price vs. Book (P/B)
49 46 64 97
Dividend Yield
1 96 96 1
Value
49 66 70 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
70 64 76 69
Profit Growth
81 76 96 34
Capital Growth
35 6 41 79
Stock Returns
86 80 77 21
Growth
91 60 91 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
89 86 80 72
Refinancing
64 75 83 95
Liquidity
92 83 68 39
Safety Safety
100 100 96 90

Similar Stocks

Discover high‑ranked alternatives to M1 Kliniken and broaden your portfolio horizons.

Lufthansa

GER:LHA
Country: Germany
Industry: Airlines
Size: X-Large
Full Stock Analysis

Volkswagen VW

GER:VOW
Country: Germany
Industry: Automobile Manufacturers
Size: XX-Large
Full Stock Analysis

Freenet

GER:FNTN
Country: Germany
Industry: Wireless Telecommunication
Size: Large
Full Stock Analysis

Drägerwerk

GER:DRW8
Country: Germany
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Frequently Asked
Questions

The company has high growth and safe financing but is expensive (low Value Rank) and has low market sentiment. This is a warning that the stock may be too expensive. This is for an experienced growth investor willing to risk overpaying, but only after conducting thorough research on future growth potential.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews